DEMOCRATIC REPUBLIC OF THE CONGO / RankWire.AI / – Congo’s Ebola outbreak has expanded at an unprecedented rate compared to previous epidemics within the country. As of August 3, authorities documented 3,874 confirmed cases and 1,751 deaths. This marks the largest recorded Ebola outbreak in Congo and ranks as the second largest globally. Remarkably, Congo reached the 1,000-case milestone just 40 days after initiating its response efforts, whereas a significant outbreak that began in 2018 took approximately 235 days to surpass that number.
Health officials officially announced the outbreak on May 15 following laboratory confirmation of Bundibugyo virus in Ituri province. Later investigations revealed that infections had actually begun several months earlier near Mongbwalu. Early on, many patients exhibited symptoms that closely resembled malaria and other common diseases. Initial testing efforts primarily focused on the more well-known Zaire Ebola species. This delay in recognition allowed the virus to spread extensively within households, clinics, mining communities, and trading hubs before testing and isolation measures were expanded.
The presence of the Bundibugyo strain has also constrained the available medical countermeasures. Vaccines and antibody treatments currently approved target Zaire ebolavirus, responsible for Congo’s epidemic from 2018 to 2020. There is no licensed vaccine or established specific treatment for Bundibugyo virus disease at present. Healthcare providers mainly depend on rapid diagnostics, patient isolation, supportive care, infection prevention, and safe burial practices. While the World Health Organization has supported efforts to enhance diagnostic capacity and develop treatment options, these initiatives only commenced after the virus had already infiltrated multiple regions.
Delayed detection hindered contact tracing efforts
The outbreak has extended beyond Mongbwalu into numerous health zones across eastern and northeastern Congo. Ituri continues to be the primary epicenter, but cases have also been reported in North Kivu, South Kivu, Haut-Uele, and Tshopo. By July 30, response teams had identified 17,863 contacts, yet follow-up coverage varied significantly, especially in regions plagued by insecurity and challenging terrain. Additionally, many new cases emerged outside the known contact lists, indicating gaps in surveillance and that not all transmission chains had been detected early enough.
Ongoing conflict has further complicated efforts to locate cases and care for patients. Armed assaults have impeded access routes, disrupted health activities, and caused some teams to halt field operations temporarily. The high mobility of populations—who frequently move between mining sites, markets, towns, and displacement camps—makes consistent monitoring of exposed contacts exceedingly difficult. Health facilities are also facing shortages of protective equipment, trained personnel, transportation, and laboratory resources. The situation is worsened by Congo’s recorded 151 infections and 44 deaths among health workers by July 30, adding to the strain on response capabilities.
Inadequate vaccination coverage and insecurity fuel the epidemic
Ebola transmits mainly through direct contact with the blood or bodily fluids of an infected individual. The risk of spread is particularly high in homes, clinics, and burial sites where infection control measures are insufficient. Over 60% of recent deaths occurred outside designated treatment centers, complicating efforts to conduct safe burials and contact investigations. In response, Congo’s health ministry, the World Health Organization, and Africa CDC have expanded laboratory testing, treatment facilities, border controls, and public education campaigns. Nonetheless, these efforts have struggled to keep pace with the rapid and widespread growth of new cases.
Uganda declared its linked outbreak over on July 28, after 42 days with no evidence of local transmission. France also reported no secondary infections resulting from its single treated case. Despite these successes, Congo remains the epicenter of ongoing transmission, with a death rate approaching 45% in early August. The epidemic’s acceleration is attributed to late detection, the absence of strain-specific vaccines and treatments, missed contacts, ongoing conflict, staff shortages, and widespread population movement. These factors collectively set this Bundibugyo epidemic apart from previous Ebola outbreaks in Congo.